Global Coagulase Plasma Market Research Report 2025(Status and Outlook)

Report Overview

Coagulase plasma, also known as coagulase test plasma, is a specialized type of plasma used in microbiology to detect the presence of the enzyme coagulase produced by Staphylococcus aureus bacteria. This test is crucial in differentiating Staphylococcus aureus from other species of staphylococci, as the presence of coagulase is a key characteristic of this pathogenic bacterium. Coagulase plasma works by promoting the coagulation of plasma in the presence of coagulase, leading to the formation of a clot. This clotting reaction is a rapid and reliable method for identifying Staphylococcus aureus in clinical samples, making coagulase plasma an essential tool in microbiology laboratories.

The market for coagulase plasma is driven by several factors. The increasing prevalence of Staphylococcus aureus infections worldwide is a significant driver for the demand for coagulase plasma. With the rise of antibiotic-resistant strains of Staphylococcus aureus, accurate and rapid identification of this bacterium is crucial for effective treatment and infection control. Additionally, the growing number of microbiology laboratories and healthcare facilities, particularly in developing regions, is contributing to the expansion of the coagulase plasma market. As these facilities strive to enhance their diagnostic capabilities, the demand for coagulase plasma and related microbiology products is expected to increase.

In addition to these drivers, technological advancements in coagulase testing methods are also shaping the market for coagulase plasma. The development of automated coagulase testing systems and the integration of molecular techniques for detecting coagulase genes are enhancing the efficiency and accuracy of coagulase testing. These advancements are not only improving the speed of diagnosis but also reducing the risk of false results, thereby driving the adoption of coagulase plasma in microbiology laboratories. Overall, the market for coagulase plasma is poised for growth due to the increasing demand for rapid and reliable diagnostic tools in the field of microbiology.

The global Coagulase Plasma market size was estimated at USD 633.15 million in 2024 and is projected to reach USD 935.45 million by 2033, exhibiting a CAGR of 5.00% during the forecast period.

This report provides a deep insight into the global Coagulase Plasma market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Coagulase Plasma Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Coagulase Plasma market in any manner.

Global Coagulase Plasma Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Pro-Lab Diagnostics

BD

TCS Biosciences

Hardy Diagnostics

Thermo Fisher Scientific

HiMedia Laboratories

Sigma-Aldrich

Mast Group

Oxoid Deutschland

Central Drug House

LABORCLIN

Market Segmentation (by Type)

Free Coagulase

Bound Coagulase

Market Segmentation (by Application)

Medical

Biotechnology

Others

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Coagulase Plasma Market
  • Overview of the regional outlook of the Coagulase Plasma Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Coagulase Plasma Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Coagulase Plasma, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.


Table of Contents 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Coagulase Plasma 1.2 Key Market Segments 1.2.1 Coagulase Plasma Segment by Type 1.2.2 Coagulase Plasma Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Coagulase Plasma Market Overview 2.1 Global Market Overview 2.1.1 Global Coagulase Plasma Market Size (M USD) Estimates and Forecasts (2020-2033) 2.1.2 Global Coagulase Plasma Sales Estimates and Forecasts (2020-2033) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Coagulase Plasma Market Competitive Landscape 3.1 Company Assessment Quadrant 3.2 Global Coagulase Plasma Product Life Cycle 3.3 Global Coagulase Plasma Sales by Manufacturers (2020-2025) 3.4 Global Coagulase Plasma Revenue Market Share by Manufacturers (2020-2025) 3.5 Coagulase Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Coagulase Plasma Average Price by Manufacturers (2020-2025) 3.7 Manufacturers Coagulase Plasma Sales Sites, Area Served, Product Type 3.8 Coagulase Plasma Market Competitive Situation and Trends 3.8.1 Coagulase Plasma Market Concentration Rate 3.8.2 Global 5 and 10 Largest Coagulase Plasma Players Market Share by Revenue 3.8.3 Mergers & Acquisitions, Expansion 4 Coagulase Plasma Industry Chain Analysis 4.1 Coagulase Plasma Industry Chain Analysis 4.2 Market Overview of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Coagulase Plasma Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 PEST Analysis 5.6.1 Industry Policies Analysis 5.6.2 Economic Environment Analysis 5.6.3 Social Environment Analysis 5.6.4 Technological Environment Analysis 5.7 Global Coagulase Plasma Market Porter's Five Forces Analysis 5.7.1 Global Trade Frictions 5.7.2 Global Trade Frictions and Their Impacts to Coagulase Plasma Market 5.8 ESG Ratings of Leading Companies 6 Coagulase Plasma Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Coagulase Plasma Sales Market Share by Type (2020-2025) 6.3 Global Coagulase Plasma Market Size Market Share by Type (2020-2025) 6.4 Global Coagulase Plasma Price by Type (2020-2025) 7 Coagulase Plasma Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Coagulase Plasma Market Sales by Application (2020-2025) 7.3 Global Coagulase Plasma Market Size (M USD) by Application (2020-2025) 7.4 Global Coagulase Plasma Sales Growth Rate by Application (2020-2025) 8 Coagulase Plasma Market Sales by Region 8.1 Global Coagulase Plasma Sales by Region 8.1.1 Global Coagulase Plasma Sales by Region 8.1.2 Global Coagulase Plasma Sales Market Share by Region 8.2 Global Coagulase Plasma Market Size by Region 8.2.1 Global Coagulase Plasma Market Size by Region 8.2.2 Global Coagulase Plasma Market Size Market Share by Region 8.3 North America 8.3.1 North America Coagulase Plasma Sales by Country 8.3.2 North America Coagulase Plasma Market Size by Country 8.3.3 U.S. Market Overview 8.3.4 Canada Market Overview 8.3.5 Mexico Market Overview 8.4 Europe 8.4.1 Europe Coagulase Plasma Sales by Country 8.4.2 Europe Coagulase Plasma Market Size by Country 8.4.3 Germany Market Overview 8.4.4 France Market Overview 8.4.5 U.K. Market Overview 8.4.6 Italy Market Overview 8.4.7 Spain Market Overview 8.5 Asia Pacific 8.5.1 Asia Pacific Coagulase Plasma Sales by Region 8.5.2 Asia Pacific Coagulase Plasma Market Size by Region 8.5.3 China Market Overview 8.5.4 Japan Market Overview 8.5.5 South Korea Market Overview 8.5.6 India Market Overview 8.5.7 Southeast Asia Market Overview 8.6 South America 8.6.1 South America Coagulase Plasma Sales by Country 8.6.2 South America Coagulase Plasma Market Size by Country 8.6.3 Brazil Market Overview 8.6.4 Argentina Market Overview 8.6.5 Columbia Market Overview 8.7 Middle East and Africa 8.7.1 Middle East and Africa Coagulase Plasma Sales by Region 8.7.2 Middle East and Africa Coagulase Plasma Market Size by Region 8.7.3 Saudi Arabia Market Overview 8.7.4 UAE Market Overview 8.7.5 Egypt Market Overview 8.7.6 Nigeria Market Overview 8.7.7 South Africa Market Overview 9 Coagulase Plasma Market Production by Region 9.1 Global Production of Coagulase Plasma by Region(2020-2025) 9.2 Global Coagulase Plasma Revenue Market Share by Region (2020-2025) 9.3 Global Coagulase Plasma Production, Revenue, Price and Gross Margin (2020-2025) 9.4 North America Coagulase Plasma Production 9.4.1 North America Coagulase Plasma Production Growth Rate (2020-2025) 9.4.2 North America Coagulase Plasma Production, Revenue, Price and Gross Margin (2020-2025) 9.5 Europe Coagulase Plasma Production 9.5.1 Europe Coagulase Plasma Production Growth Rate (2020-2025) 9.5.2 Europe Coagulase Plasma Production, Revenue, Price and Gross Margin (2020-2025) 9.6 Japan Coagulase Plasma Production (2020-2025) 9.6.1 Japan Coagulase Plasma Production Growth Rate (2020-2025) 9.6.2 Japan Coagulase Plasma Production, Revenue, Price and Gross Margin (2020-2025) 9.7 China Coagulase Plasma Production (2020-2025) 9.7.1 China Coagulase Plasma Production Growth Rate (2020-2025) 9.7.2 China Coagulase Plasma Production, Revenue, Price and Gross Margin (2020-2025) 10 Key Companies Profile 10.1 Pro-Lab Diagnostics 10.1.1 Pro-Lab Diagnostics Basic Information 10.1.2 Pro-Lab Diagnostics Coagulase Plasma Product Overview 10.1.3 Pro-Lab Diagnostics Coagulase Plasma Product Market Performance 10.1.4 Pro-Lab Diagnostics Business Overview 10.1.5 Pro-Lab Diagnostics SWOT Analysis 10.1.6 Pro-Lab Diagnostics Recent Developments 10.2 BD 10.2.1 BD Basic Information 10.2.2 BD Coagulase Plasma Product Overview 10.2.3 BD Coagulase Plasma Product Market Performance 10.2.4 BD Business Overview 10.2.5 BD SWOT Analysis 10.2.6 BD Recent Developments 10.3 TCS Biosciences 10.3.1 TCS Biosciences Basic Information 10.3.2 TCS Biosciences Coagulase Plasma Product Overview 10.3.3 TCS Biosciences Coagulase Plasma Product Market Performance 10.3.4 TCS Biosciences Business Overview 10.3.5 TCS Biosciences SWOT Analysis 10.3.6 TCS Biosciences Recent Developments 10.4 Hardy Diagnostics 10.4.1 Hardy Diagnostics Basic Information 10.4.2 Hardy Diagnostics Coagulase Plasma Product Overview 10.4.3 Hardy Diagnostics Coagulase Plasma Product Market Performance 10.4.4 Hardy Diagnostics Business Overview 10.4.5 Hardy Diagnostics Recent Developments 10.5 Thermo Fisher Scientific 10.5.1 Thermo Fisher Scientific Basic Information 10.5.2 Thermo Fisher Scientific Coagulase Plasma Product Overview 10.5.3 Thermo Fisher Scientific Coagulase Plasma Product Market Performance 10.5.4 Thermo Fisher Scientific Business Overview 10.5.5 Thermo Fisher Scientific Recent Developments 10.6 HiMedia Laboratories 10.6.1 HiMedia Laboratories Basic Information 10.6.2 HiMedia Laboratories Coagulase Plasma Product Overview 10.6.3 HiMedia Laboratories Coagulase Plasma Product Market Performance 10.6.4 HiMedia Laboratories Business Overview 10.6.5 HiMedia Laboratories Recent Developments 10.7 Sigma-Aldrich 10.7.1 Sigma-Aldrich Basic Information 10.7.2 Sigma-Aldrich Coagulase Plasma Product Overview 10.7.3 Sigma-Aldrich Coagulase Plasma Product Market Performance 10.7.4 Sigma-Aldrich Business Overview 10.7.5 Sigma-Aldrich Recent Developments 10.8 Mast Group 10.8.1 Mast Group Basic Information 10.8.2 Mast Group Coagulase Plasma Product Overview 10.8.3 Mast Group Coagulase Plasma Product Market Performance 10.8.4 Mast Group Business Overview 10.8.5 Mast Group Recent Developments 10.9 Oxoid Deutschland 10.9.1 Oxoid Deutschland Basic Information 10.9.2 Oxoid Deutschland Coagulase Plasma Product Overview 10.9.3 Oxoid Deutschland Coagulase Plasma Product Market Performance 10.9.4 Oxoid Deutschland Business Overview 10.9.5 Oxoid Deutschland Recent Developments 10.10 Central Drug House 10.10.1 Central Drug House Basic Information 10.10.2 Central Drug House Coagulase Plasma Product Overview 10.10.3 Central Drug House Coagulase Plasma Product Market Performance 10.10.4 Central Drug House Business Overview 10.10.5 Central Drug House Recent Developments 10.11 LABORCLIN 10.11.1 LABORCLIN Basic Information 10.11.2 LABORCLIN Coagulase Plasma Product Overview 10.11.3 LABORCLIN Coagulase Plasma Product Market Performance 10.11.4 LABORCLIN Business Overview 10.11.5 LABORCLIN Recent Developments 11 Coagulase Plasma Market Forecast by Region 11.1 Global Coagulase Plasma Market Size Forecast 11.2 Global Coagulase Plasma Market Forecast by Region 11.2.1 North America Market Size Forecast by Country 11.2.2 Europe Coagulase Plasma Market Size Forecast by Country 11.2.3 Asia Pacific Coagulase Plasma Market Size Forecast by Region 11.2.4 South America Coagulase Plasma Market Size Forecast by Country 11.2.5 Middle East and Africa Forecasted Sales of Coagulase Plasma by Country 12 Forecast Market by Type and by Application (2026-2033) 12.1 Global Coagulase Plasma Market Forecast by Type (2026-2033) 12.1.1 Global Forecasted Sales of Coagulase Plasma by Type (2026-2033) 12.1.2 Global Coagulase Plasma Market Size Forecast by Type (2026-2033) 12.1.3 Global Forecasted Price of Coagulase Plasma by Type (2026-2033) 12.2 Global Coagulase Plasma Market Forecast by Application (2026-2033) 12.2.1 Global Coagulase Plasma Sales (K Units) Forecast by Application 12.2.2 Global Coagulase Plasma Market Size (M USD) Forecast by Application (2026-2033) 13 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings